Stockscreener 앱 받기
11.68
0.26%
-0.03
전일 마감가:
$11.71
열려 있는:
$11.7
하루 거래량:
83,453
Relative Volume:
0.38
시가총액:
$395.51M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-1.0665
EPS:
-10.9518
순현금흐름:
$-18.07M
1주 성능:
-1.35%
1개월 성능:
-5.88%
6개월 성능:
-0.60%
1년 성능:
+5.61%
1일 변동 폭
$11.54
$12.05
1주일 범위
$11.40
$12.54
52주 변동 폭
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.68 | 396.53M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | TD Cowen | Buy |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily
Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada
Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com India
Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus
Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com
Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - Улправда
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com
Published on: 2026-01-09 06:38:29 - Улправда
Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - Улправда
Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 105.93% Potential Upside in Genetic Medicine - DirectorsTalk Interviews
Suvretta Capital Management, LLC Acquires Additional Shares in B - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com South Africa
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Purchases 50,000 Shares of Stock - MarketBeat
Wall Street analysts predict an 87.48% upside in Benitec Biopharma (BNTC): Here's what you should know - MSN
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares of Stock - Defense World
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 By Investing.com - Investing.com UK
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares - MarketBeat
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock - MarketBeat
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 - Investing.com
Why Benitec Biopharma Inc. stock attracts global investorsQuarterly Market Review & Community Verified Trade Alerts - Улправда
Benitec Biopharma Earnings Notes - Trefis
Can Benitec Biopharma Inc. stock outperform in 2025 bull market - Улправда
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting - MSN
Will Benitec Biopharma Inc. stock attract more institutional investorsWeekly Investment Report & Smart Investment Allocation Insights - DonanımHaber
Entry Recap: Can Benitec Biopharma Inc. stock outperform in 2025 bull marketLong Setup & Daily Chart Pattern Signals - Улправда
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Benitec Biopharma Inc 주식 (BNTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '25 |
Buy |
12.85 |
50,000 |
642,500 |
9,620,075 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 26 '25 |
Buy |
13.10 |
16,836 |
220,552 |
9,634,395 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 22 '25 |
Buy |
12.08 |
19,542 |
236,067 |
9,577,475 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 19 '25 |
Buy |
11.48 |
16,384 |
188,088 |
9,560,825 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 18 '25 |
Buy |
11.24 |
10,215 |
114,817 |
9,546,875 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 07 '25 |
Buy |
13.50 |
1,481,481 |
19,999,994 |
9,538,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 31 '25 |
Buy |
12.83 |
16,497 |
211,736 |
8,807,805 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
4.73%
0.92%
자본화:
|
볼륨(24시간):